QID|1|What are the effects of calcium on the physical properties of mucus from CF patients? 
483|0.231893
824|0.169105
497|0.164714
436|0.163329
532|0.150458
739|0.136112
525|0.133891
440|0.130253
922|0.125790
752|0.123895
52|0.121188
972|0.120365
964|0.117774
590|0.116354
498|0.108395
480|0.108149
301|0.107167
954|0.105672
709|0.103154
1184|0.102796
QID|2|Can one distinguish between the effects of mucus hypersecretion and infection on the submucosal glands of the respiratory tract in CF?
483|0.231893
590|0.223402
824|0.169105
497|0.167709
497|0.164714
436|0.163329
532|0.150458
739|0.136112
525|0.133891
1166|0.133812
440|0.130253
922|0.125790
752|0.123895
52|0.121188
972|0.120365
964|0.117774
590|0.116354
160|0.114791
1219|0.112130
498|0.108395
QID|3|How are salivary glycoproteins from CF patients different from those of normal subjects?
483|0.231893
590|0.223402
853|0.214223
631|0.196795
1202|0.195109
77|0.175032
824|0.169105
497|0.167709
497|0.164714
436|0.163329
438|0.157587
1192|0.151610
499|0.150985
532|0.150458
956|0.145338
1060|0.140606
739|0.136112
525|0.133891
1166|0.133812
440|0.130253
QID|4|What is the lipid composition of CF respiratory secretions?
873|0.270885
602|0.240345
483|0.231893
590|0.223402
853|0.214223
631|0.196795
1202|0.195109
723|0.185840
77|0.175032
824|0.169105
497|0.167709
497|0.164714
436|0.163329
438|0.157587
1192|0.151610
499|0.150985
532|0.150458
956|0.145338
864|0.141425
925|0.141299
QID|5|Is CF mucus abnormal?
497|0.404148
922|0.310110
972|0.294048
590|0.283284
873|0.270885
709|0.256416
151|0.247904
752|0.243762
602|0.240345
483|0.231893
590|0.223402
853|0.214223
631|0.196795
1202|0.195109
436|0.190688
480|0.186005
723|0.185840
498|0.176757
77|0.175032
824|0.173965
QID|6|What is the effect of water or other therapeutic agents on the physical properties (viscosity, elasticity) of sputum or bronchial secretions from CF patients?
497|0.404148
922|0.310110
972|0.294048
590|0.283284
873|0.270885
709|0.256416
151|0.247904
752|0.243762
602|0.240345
440|0.235275
483|0.231893
590|0.223402
853|0.214223
31|0.206573
631|0.196795
1202|0.195109
436|0.190688
480|0.186005
723|0.185840
498|0.176757
QID|7|Are mucus glycoproteins degraded differently in CF patients as compared to those from normal subjects?
497|0.404148
922|0.310110
972|0.294048
590|0.283284
873|0.270885
709|0.256416
151|0.247904
752|0.243762
602|0.240345
440|0.235275
483|0.231893
590|0.223402
853|0.214223
31|0.206573
631|0.196795
1202|0.195109
436|0.190688
480|0.186005
723|0.185840
498|0.176757
QID|8|What histochemical differences have been described between normal and CF respiratory epithelia?
497|0.404148
922|0.310110
972|0.294048
590|0.283284
873|0.270885
709|0.256416
151|0.247904
752|0.243762
602|0.240345
440|0.235275
483|0.231893
590|0.223402
853|0.214223
31|0.206573
631|0.196795
1202|0.195109
436|0.190688
480|0.186005
723|0.185840
498|0.176757
QID|9|What is the association between liver disease (cirrhosis) and vitamin A metabolism in CF?
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
440|0.235275
483|0.231893
875|0.230610
590|0.223402
853|0.214223
31|0.206573
157|0.203248
1186|0.200566
QID|10|What is the role of Vitamin E in the therapy of patients with CF?
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
440|0.235275
483|0.231893
875|0.230610
590|0.223402
853|0.214223
31|0.206573
157|0.203248
1186|0.200566
QID|11|What is the difference between meconium ileus and meconium plug syndrome?
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
832|0.222447
1060|0.222215
QID|12|What abnormalities of amino acid transport have been described in the small bowel of CF patients?
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
832|0.222447
1060|0.222215
QID|13|What are the clinical or biochemical features of pancreatitis in CF patients?
899|0.423163
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
832|0.222447
QID|14|What non-invasive tests can be performed for the evaluation of exocrine pancreatic function in patients with CF?
899|0.423163
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
832|0.222447
QID|15|What are the hepatic complications or manifestations of CF?
899|0.423163
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
832|0.222447
QID|16|What are the gastrointestinal complications of CF after the neonatal period (exclude liver disease and meconium ileus)?
899|0.423163
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
832|0.222447
QID|17|What is the most effective regimen for the use of pancreatic enzyme supplements in the treatment of CF patients?
899|0.423163
497|0.404148
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
832|0.222447
QID|18|Is dietary supplementation with bile salts of therapeutic benefit to CF patients?
899|0.423163
497|0.404148
1012|0.369127
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
QID|19|What complications of pancreatic enzyme therapy have been reported in CF patients?
899|0.423163
497|0.404148
1012|0.369127
413|0.327613
922|0.310110
972|0.294048
590|0.283284
1104|0.278997
873|0.270885
795|0.268480
295|0.258224
709|0.256416
151|0.247904
752|0.243762
602|0.240345
96|0.239566
440|0.235275
483|0.231893
875|0.230610
590|0.223402
QID|20|What is the effect of treatment of CF patients with essential fatty acid supplements?
899|0.423163
497|0.404148
126|0.380354
1012|0.369127
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
873|0.270885
795|0.268480
295|0.258224
709|0.256416
285|0.252821
151|0.247904
752|0.243762
QID|21|Does pancreatic insufficiency in CF patients affect their ability to absorb or metabolize iron?
899|0.423163
497|0.404148
126|0.380354
1012|0.369127
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
873|0.270885
795|0.268480
295|0.258224
709|0.256416
285|0.252821
151|0.247904
752|0.243762
QID|22|What is the frequency of CF in non-Caucasian populations?
899|0.423163
497|0.404148
126|0.380354
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
295|0.258224
709|0.256416
285|0.252821
QID|23|What congenital or hereditary diseases or conditions have been found in association with CF?
899|0.423163
497|0.404148
126|0.380354
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
295|0.258224
709|0.256416
285|0.252821
QID|24|What are the characteristics of patients in whom CF is incompletely manifested?
899|0.423163
497|0.404148
126|0.380354
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
295|0.258224
709|0.256416
285|0.252821
QID|25|What evidence is there that the genetic basis for CF involves more than one gene?
899|0.423163
497|0.404148
126|0.380354
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
295|0.258224
709|0.256416
285|0.252821
QID|26|What is the heterozygote advantage in CF?
899|0.423163
497|0.404148
126|0.380354
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
295|0.258224
709|0.256416
1057|0.253413
QID|27|What is the concordance of clinical or biochemical manifestations of CF in sibling pairs (both of whom have CF)?
899|0.423163
497|0.404148
126|0.380354
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
902|0.259985
295|0.258224
709|0.256416
QID|28|What is the incidence of male fertility in CF?
899|0.423163
497|0.404148
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
902|0.259985
295|0.258224
QID|29|What is the pathology of the reproductive system (male or female) in CF?
899|0.423163
497|0.404148
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
902|0.259985
295|0.258224
QID|30|What are the results of genetic counseling of families of children with CF?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
902|0.259985
QID|31|What are the major psychological or social effects of CF on patients and their families?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
902|0.259985
QID|32|What factors influence compliance with prescribed therapy in CF patients?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|33|What conditions or factors lead to erroneous sweat tests?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|34|What alternative techniques other than the classical Gibson-Cooke quantitative pilocarpine iontophoresis test (with titrimetric analysis of chloride) are available for sweat testing; what are their relative advantages and disadvantages?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|35|Has any CF patient been found to have consistently normal sweat tests? 
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|36|What is the concentration of potassium in sweat from CF patients?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|37|What techniques are available for screening of newborn infants for CF, and what factors contribute to erroneous results of these tests?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|38|Can CF be diagnosed prenatally?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|39|How may heterozygotes for CF be identified?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|40|Other than the sweat test, what techniques may be useful (beyond the neonatal period) for the diagnosis of CF?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|41|Is Vitamin D metabolism normal in CF patients?
899|0.423163
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
327|0.357829
413|0.327613
207|0.323325
922|0.310110
387|0.307530
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
537|0.278561
104|0.272507
873|0.270885
795|0.268480
QID|42|What abnormalities of insulin secretion or insulin metabolism occur in CF patients?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
207|0.323325
922|0.310110
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
QID|43|Is salt (sodium and/or chloride) transport/permeability abnormal in CF?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
207|0.323325
922|0.310110
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
QID|44|What structural or enzymatic differences are there between fibroblasts from CF patients and non-CF patients?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
207|0.323325
922|0.310110
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
QID|45|What abnormalities of prostaglandin metabolism have been described in CF patients?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
207|0.323325
922|0.310110
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
QID|46|What are the properties and activity of galactosyltransferase enzymes from CF patients?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
207|0.323325
922|0.310110
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
QID|47|What differences between normal subjects and CF patients have been described in the function or metabolism of hormones?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
207|0.323325
922|0.310110
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
QID|48|Do fibroblasts from CF patients grow at a normal rate?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
207|0.323325
922|0.310110
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
286|0.282751
1104|0.278997
QID|49|Is RNA methylation or polyamine metabolism normal in CF patients?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
922|0.310110
138|0.308605
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
QID|50|What defects in the synthesis or metabolism of cyclic nucleotides have been described in CF patients?
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
922|0.310110
138|0.308605
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
QID|51|What circulating or secreted "factors" have been described in CF patients? ("Factors" are unidentified biologically active molecules thought to play some pathogenetic role in cystic fibrosis).
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
922|0.310110
138|0.308605
387|0.307530
208|0.303558
916|0.295954
972|0.294048
590|0.283284
QID|52|What is known about prolactin in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
922|0.310110
138|0.308605
387|0.307530
208|0.303558
916|0.295954
972|0.294048
QID|53|Does secretory IgA protect CF patients against bacterial colonization or infection?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
922|0.310110
138|0.308605
387|0.307530
208|0.303558
916|0.295954
972|0.294048
QID|54|What is the relationship of allergy or hypersensitivity to lung disease in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|55|What are the interactions between proteases (endogenous or bacterial origin) and antiproteases in the lungs of CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|56|What is the relationship between nutrition and pulmonary host defenses against bacterial infection in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|57|What is the pathophysiologic role of circulating antibodies to Pseudomonas aeruginosa in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|58|What is the immunologic response to pulmonary infection in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|59|What immunologic abnormalities have been found in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|60|What are the effects of CF on the pulmonary circulation?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|61|Is there a defect in mucociliary transport (clearance) in the respiratory tract of CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|62|What are the clinical features of lung disease in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|63|What are the biochemical or microscopic characteristics of airway inflammation in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|64|How does lung function change with time in CF patients? (time periods greater than a day)
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|65|What are the abnormalities of pulmonary function in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|66|What are the pathologic features of lung disease in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|67|What is the prognosis for patients who have had an episode of respiratory failure?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|68|What are the effects of bronchodilators in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
670|0.298336
QID|69|What is the best way to treat pneumothorax in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
583|0.343091
413|0.327613
701|0.324168
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
208|0.303558
QID|70|What is the treatment for and prognosis of hemoptysis in CF patients?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
413|0.327613
701|0.324168
143|0.323674
207|0.323325
487|0.320633
922|0.310110
138|0.308605
387|0.307530
QID|71|What is the prognosis for infants with wheezing and cystic fibrosis?
405|0.500182
899|0.423163
336|0.416095
497|0.404148
997|0.392565
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
56|0.331042
413|0.327613
701|0.324168
143|0.323674
207|0.323325
487|0.320633
922|0.310110
QID|72|What is the best treatment for nasal polyps in CF patients?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
701|0.324168
143|0.323674
207|0.323325
QID|73|How effective is bronchial lavage in CF patients?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
143|0.323674
QID|74|What are the results of mechanical ventilation in CF patients with respiratory failure?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|75|What is the best treatment for pulmonary hypertension and/or cor pulmonale in CF patients?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|76|What are the effects of exercise training programs on lung function in CF patients?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|77|What techniques are effective in promoting clearance of mucus from the lungs of CF patients?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|78|What special considerations are there for treatment of CF patients with antibiotics (ie, are the pharmacodynamics of antibiotics different in CF patients, or are there other special problems peculiar to CF)?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|79|What is the role of orally administered antibiotics in the treatment of CF patients?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|80|What is the evidence that combination therapy with aminoglycosides and semisynthetic penicillins is more effective than therapy with either alone?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|81|How effective are inhalations of mucolytic agents in the treatment of CF patients?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|82|What is the role of aerosols in the treatment of lung disease in CF patients?
405|0.500182
769|0.462503
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
701|0.324168
QID|83|What is the role of bacterial phagocytosis (by alveolar macrophages or polymorphonuclear leukocytes) in lung disease in CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
QID|84|What is the relationship between Haemophilus influenzae and Pseudomonas aeruginosa in CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
QID|85|Do CF patients ever develop infection in organs other than the lung? If so, in what organs?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
QID|86|What is the role of bacteria other than Pseudomonas aeruginosa, Staphylococcus aureus, or Haemophilus influenzae in the pathogenesis of lung disease in CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
QID|87|What is the role of fungi in the pathogenesis of lung disease in CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
56|0.331042
413|0.327613
223|0.325102
QID|88|What is the role of viral infection in the lung disease of CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
413|0.327613
QID|89|What is the epidemiology of Pseudomonas aeruginosa in CF patients? Specifically, do CF patients spread Pseudomonas aeruginosa to other patients or to other individuals (family)?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
413|0.327613
QID|90|What factors are responsible for the appearance of mucoid strains of Pseudomonas aeruginosa in CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
413|0.327613
QID|91|What are the unusual manifestations of CF (other than lung disease or exocrine pancreatic insufficiency)?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
413|0.327613
QID|92|What is the prognosis for survival of patients with CF?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
QID|93|Do CF patients have normal intelligence?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
QID|94|What animal models are available which are relevant to CF?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
QID|95|What abnormalities of skeletal muscle function or structure have been found in CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
QID|96|Is there an increased incidence of dental problems (eg, caries or periodontal disease) in CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
QID|97|Is oxygen transport by red blood cells abnormal in CF patients?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
QID|98|What are the effects of CF on the development and/or function of the brain and central nervous system?
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
801|0.345972
583|0.343091
681|0.340401
612|0.331955
56|0.331042
QID|99|Are there abnormalities of taste in CF patients?
267|0.542393
405|0.500182
769|0.462503
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
323|0.349031
801|0.345972
583|0.343091
681|0.340401
QID|100|What is the incidence of and treatment for hypertrophic osteoarthropathy in CF patients?
267|0.542393
182|0.512564
405|0.500182
769|0.462503
578|0.436787
18|0.424806
899|0.423163
336|0.416095
497|0.404148
997|0.392565
911|0.388232
546|0.383017
126|0.380354
476|0.370917
1012|0.369127
316|0.363913
327|0.357829
659|0.356542
323|0.349031
801|0.345972
